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synthesize the data while considering the clinical implications of the findings, especially when using person-centered analyses. Lockwood et al. (2019) conducted a systematic review of symptom clusters in patients with CKD. Results indicated that the number of clusters varied from two to five across studies, there were similarities in clusters across studies, and individual symptoms comprising a cluster varied widely. The authors also found that several clusters correlated with patient outcomes, including health-related quality of life and mortality. These findings suggest that identifying symptom clusters may inform clinical strategies to improve outcomes along the trajectory of chronic conditions. The findings from Ryan et al. (2019) and Lockwood et al. (2019) are advancing the science of symptom clusters from a methodological and empirical perspective. Investigators can now have more confidence in choosing the appropriate cluster analytic technique for their studies and those studying individuals with ACS and CKD have a better understanding of how symptoms cluster in their populations.
We know gaps remain in our knowledge of mechanisms of symptom expression such as inflammation or immune function and whether symptoms are mechanistically related. There have also been limitations to prior symptom cluster research including lack of standard symptom measures, study aims which lack theoretical rationale, inclusion of homogeneous sample populations, and justification for analytic methods. We must continue to explore symptom clusters across populations and conditions using theory and sound methods. We cannot yet say that the sum (symptom clusters) is more clinically relevant than the parts (individual symptoms).
However, we can say patients frequently experience multiple symptoms simultaneously. Utilizing sound analytic methods and clearly articulated rationale will provide evidence to better inform patients of the importance of monitoring and reporting symptoms as well as seeking care for severe symptoms, a change in health status, or for acute conditions. New knowledge of symptom clusters may also provide clinicians with valuable data on the effectiveness of treatments or emerging treatment options. 
